OpenAlex records 40 works, 1,175 citations, and an h-index of 13 for Narayanan Raghupathy, with topics concentrated in biology, genetics, and computational biology. Citation flow peaked around 2015β2018, driven by two flagship papers: a Nature article defining proteome-wide consequences of genetic variation (430 citations, a HarvardβJackson Laboratory cross-disciplinary effort) and a PLoS Genetics study on PRDM9-driven recombination hotspot erosion (160 citations). Recent years (2022β2026) show steady output but low new citations, consistent with an author whose impact comes from methods embedded in large consortia.
The 2026 ProteoEM preprint is simulation-only: it recovers proteoform abundances from iterative affinity traces with total-variation error of 0.013 at 20,000 traces versus 0.19β0.24 for hard-call baselines, sensitivity 0.978, FDR 0.010, and exact equivalence-class compression verified against an independent projected-gradient optimizer to within 6.6 Γ 10β»ΒΉβΆ in fitted weights . The author is transparent about blindspots: the emission matrix Q is never measured from real probe binding, recovery yields are assumed externally calibrated, no uncertainty intervals are provided, and no experimental validation exists. Funding is declared as none, and a conflict of interest is disclosed (founder of Tensoromics LLC), which warrants attention but is not unusual for consulting-based computational biologists. The work is engineering-sound (100 tests, locked dependencies, Zenodo archive) but its real-world value is unproven.
Confidence: moderate. The preprint demonstrates estimator correctness under oracle conditions, not assay performance β the author explicitly frames results as bookkeeping tests. Disconfirmation would require applying ProteoEM to experimental single-molecule affinity data with independently calibrated Q and known spike-in compositions; if estimates did not track known abundances better than hard-call baselines under realistic noise, the central claim would weaken.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.